放療醫(yī)學(xué)名詞

發(fā)表時間:2018/07/30 00:00:00 瀏覽次數(shù):17406

字體大小: 【小】【中】【大】

三維適形放射治療	3D- CRT 3dimensional comformal radiation therapy
主動呼吸控制技術(shù)	ABC active breath control
自體骨髓移植	ABMT autologous bone marrow transplantation
加速分割	AF accelerated fractionation
加速超分割	AHF accelerated hyperfractionation
適應(yīng)性照射	ART adaptive radiotherapy
毛細(xì)血管擴(kuò)張性共濟(jì)失調(diào)	AT Ataxia Talangiectasia
基準(zhǔn)劑量	BD basal dose
生物等效劑量	BED biologically effective dose
射束方向視圖	BEV beam eye view
身體質(zhì)量指數(shù)	BMI body mass index
血氧水平依賴法	BOLD blood-oxygen-level-dependent
生物反應(yīng)調(diào)節(jié)劑	BRMs biological response modifiers
生物靶區(qū)	BTV biological target volume
同時小野加量加速超分割放療	CBHART concomitant boost hyperfractionated accelerated radiation therapy
兒童癌癥研究組織	CCG Children’s Cancer Group
細(xì)胞周期依賴性蛋白激酶	CDK cyclin-dependent kinase
常規(guī)分割	CF conventional fractionation
連續(xù)加速超分割放療	CHART continuous hyperfractionated accelerated radiation therapy
靶區(qū)覆蓋指數(shù)	CI coverage index
宮頸上皮內(nèi)瘤變	CIN cerbical intraepithelial neoplasia
抵劑量率持續(xù)照射	CLDR continuous low dose rate radiotherapy
皮膚惡性淋巴瘤	CML cutaneous malignant lymphoma
床角預(yù)覽視圖	CPV coach’s preview
計算機(jī)體層顯影	CT computed tomography
臨床靶區(qū)	CTV clinical target volume
原發(fā)灶不明的轉(zhuǎn)移癌	CUP carcinoma of unknown primary
真皮內(nèi)樹突狀細(xì)胞	DDCs dermal dendritic cells
無瘤生存	DFS disease free survival
劑量修飾因子	DMF dose modifying factor
蛋白質(zhì)交聯(lián)	DPC DNA protein cross-linking DNA-
劑量減少系數(shù)	DRF dose reduction factor
數(shù)字重建圖像	DRR digitally reconstructed radiography
數(shù)字減影血管造影	DSA digital subtractive angiography
雙鏈斷裂	DSB double strand break
劑量-體積直方圖	DVH dose volume histograms
電子反向散射因子	EBF electron backscatter factor
細(xì)胞外基質(zhì)	ECM extracellular matrix
表皮生長因子受體	EGFR epithelial growth factor receptor
逐步遞量加速超分割放療	EHART escalating hyperfractionated accelerated radiation gherapy
靶外體積指數(shù)	EI external volume index
電子射野影像系統(tǒng)	EPID electronic portal imaging device
等效均一劑量	EUD dffective uniform dose
氟代脫氧葡萄糖	18F-FDG 18F-fluorodeoxyglucose
濾泡中心性淋巴瘤	FCCL follicular center cell lymphoma
分次劑量因子	FDF fractionation-dosage factor
高劑量率分次近距離治療	FHDR fractionated high dose rate brachytherapy
纖維板層樣肝細(xì)胞肝癌	FL-HCC fibrolamellar hepatocellular carcinoma
局灶性結(jié)節(jié)增生	FNH focal nodular hyperplasia
分次立體定向放射治療	FSRT fractionated stereotactic radiotherapy
功能亞單元	FSU functional subunits
生殖細(xì)胞瘤	GCT germ cell tumor
腫瘤靶區(qū)或肉眼靶區(qū)	GTV gross tumor volume
肝細(xì)胞腺瘤	HA hepatocellular adenoma
熱療加化療	HC hyperthermia and chemotherapy
肝細(xì)胞肝癌	HCC hepatocellular carcinoma
超劑量區(qū)	HD hyperdose sleeve
超分割	HF hyperfractionation
靶區(qū)劑量均勻性指數(shù)	HI relative dose homogeneity index
熱療加放療	HR hyperthermia and radiation
熱療加放化療	HRC hyperthermia and radiochemotherapy
半價層	HVL half value layer
免疫細(xì)胞瘤	IC immunocytoma
間隔細(xì)胞減滅術(shù)	ICR interval cytoreductive or intervening cytoreduction
國際輻射單位與測量委員會	ICRU International Commission on Radiation units and Measurements
影像學(xué)引導(dǎo)的適應(yīng)性照射	IGART image guided adaptive radiotherapy
影像學(xué)引導(dǎo)的放射治療	IGRT image guided radiotherapy
內(nèi)邊界	IM internal margin
弧形調(diào)強(qiáng)技術(shù)	IMAT intensity modulated arc therapy
調(diào)強(qiáng)放射治療	IMRT intensity modulated radiation therapy
全盆調(diào)強(qiáng)放射治療	IM-WPRT intensity-modulated whole pelvic radiotherapy
免疫增值性小腸病	IPSID immunoproliferative small intestinal disease
國際標(biāo)準(zhǔn)化組織	ISO international Organization for Standardization
內(nèi)靶區(qū)	ITV internal target volume
照射靶區(qū)	IV irradiation volume
表皮膠原細(xì)胞	KCs keratinocytes
后程加速超分割放療	LCHART late-course hyperfractionated accelerated radiation therapy
朗罕氏細(xì)胞	LCs Langerhans cells
致死損傷	LD lethal damage
正常晚反應(yīng)組織	LENT late effective normal tissues
線性能量傳遞	LET linear energy transfer
局部加溫	LH local hyperthermia
標(biāo)記指數(shù)	LI labeling index
線性最小二乘法	LLS linear least squares
模型或線性二次模型	LQ linear quadratic model LQ
平均中心劑量	MCD mean central dose
多葉調(diào)強(qiáng)補(bǔ)償器	MIMiC multivaane intensity modulation compensator
多葉準(zhǔn)直器	MLC multileaf collimator
磁共振成像	MRI magnetic resonance imaging
最小靶劑量	MTD minimum target dose
溫和加溫	MTH mild temperature hyperthermia
機(jī)器跳數(shù)	MU monitor unit
美國綜合癌癥工作者	NCCN National Comprehensive Cancer Network
無疾病證據(jù)	NED no evidence of disease
神經(jīng)纖維瘤病	NF neurofibromatosis
非霍奇金淋巴瘤	NHL non-Hodgkin Lymphoma
非小細(xì)胞肺癌	NSCLC non-small cell lung cancer
名義標(biāo)準(zhǔn)劑量	NSD nominal standard dose
非精原細(xì)胞性生殖細(xì)胞瘤	NSGCT nonseminomatous germ cell tumor
正常組織并發(fā)癥概率	NTCP normal tissue complication probability
離軸比	OAR off axial ratio
敏感器官	OAR organ at risk
氧增強(qiáng)比	OER oxygen enhancement ratio
超劑量體積指數(shù)	OI overdose volume index
隱匿原發(fā)灶	OPM ocult primary malignancy
射野輸出因子	OUF output factor
預(yù)防性全腦照射	PCI propylactic cranial irradiation
原發(fā)性皮膚惡性淋巴瘤	PCML primary cutaneous malignant lymphoma
百分深度劑量	PDD percentage depth dose
脈沖劑量率近距離治療	PDRR pulsed dose rate brachytherapy
正電子發(fā)射斷層掃描	PET positron emission tomography
防護(hù)系數(shù)	PF protection factor
潛在致死損傷	PLD potential lethal damage
外周淋巴結(jié)地址素	PNAd peripheral node addressin
原始神經(jīng)外胚層腫瘤	PNETs primitive neuroectodermal tumor
胰腺癌胚抗原	POA pancreatic oncofetal antigen
前列腺特異抗原	PSA prostate specific antigen
精確放療	PT precision radiotherapy
經(jīng)皮腔內(nèi)冠狀動脈成型術(shù)	PTCA percutaneous transluminal coronary angioplasty
計劃靶區(qū)	PTV planning target volume
無并發(fā)癥控制概率	PUC probability of uncomplicated control
多不飽和脂肪酸	PUFA polyunsaturated fatty acid
質(zhì)量保證／質(zhì)量控制	QA/QC quality assurance/quality control
生活質(zhì)量	QOL quality of life
二次規(guī)劃法	QP quadratic programming
相對生物效應(yīng)	RBE relative biological effectiveness
參考劑量	RD reference dose
治療室內(nèi)視圖	REV room＇s eye view
區(qū)域加溫	RH regional hyperthermia
源軸距	SAD source axis distance
皮膚相關(guān)淋巴樣組織	SALT skin associated lymphoid tissue
散射空氣比	SAR scatter air ratio
分段加速超分割放療	SCHART split-course hyperfractionated accelerated radiation therapy
小細(xì)胞肺癌	SCLC small cell lung cancer
增敏比	SER sensitization enhancement ratio
加權(quán)綜合指數(shù)	SI sum index
大野照射及小野追加劑量照射	SIB simultaneously integrated boosting
國際兒童腫瘤研究組織	SIOP International Society for Paediatric Oncology
皮膚免疫系統(tǒng)	SIS skin immune system
亞致死損傷	SLD sublethal damage
哨位淋巴結(jié)	SLN sentinel lymph node
哨位淋巴結(jié)活檢技術(shù)	SLNB sentinel lymph node biopsy
擺位邊界	SM set-up margin
散射最大劑量比	SMR scatter maximum ratio
擴(kuò)展布拉格峰	SOBP spread out Bragg peak
單光子發(fā)射型計算機(jī)掃描	SPECT single photo emmision computerized tomography
散射體模比	SPR scatter phantom ratio
立體定向放射外科	SRS stereotactic radiosurgery
立體定向放射治療	SRT stereotactic radiation therapy
單鏈斷裂	SSB single strand break
源皮距	SSD source skin distance
源瘤距	STD source tumor distance
上腔靜脈綜合征	SVCS superior vena cave syndrome
奇異值分解法	SVD singular value decomposition
腫瘤相關(guān)抗原	TAA tumor associated antigen
經(jīng)導(dǎo)管動脈栓塞術(shù)	TAE transcatheter arterial embolization
組織空氣比	TAR tissue air ratio
腫瘤控制劑量	TCD tumor control dose
腫瘤控制概率	TCP tumor control probability
熱增強(qiáng)比	TER thermal enhancement ratio
治療增益系數(shù)（因子）	TGF therapeutic gain factor
熱釋光劑量計	TLD thermoluminescence dosimeters
組織最大劑量比	TMR tissue maximum ratio
潛在倍增時間	Tpot potertial doubling time
組織體模比	TPR tissue phantom ratio
治療計劃系統(tǒng)	TPS treatment planning system
治療比	TR therapeutic ratio
電子線全身照射	TSEI total skin electron irradiation
治療靶區(qū)	TV treatment volume
治療體積比	TVR treatment volume ratio
程序外DNA合成	UDS unscheduled DNA synthesis
國際抗癌聯(lián)盟	UICC International Union Against Cancer
血管內(nèi)皮生長因子	VEGF vascular endothelial growth factor
全身加溫	WBH whole body huperthermia

上一篇：護(hù)理診斷術(shù)語

下一篇：普外科醫(yī)學(xué)名詞